Results 131 to 140 of about 10,818,476 (313)

NAPRT loss promotes lung tumor initiation and growth through AKT signaling independently of NAD+ biosynthesis

open access: yesMolecular Oncology, EarlyView.
Loss of NAPRT promotes lung tumor initiation and growth through a noncanonical mechanism, independent of its role in NAD+ biosynthesis. Mechanistically, NAPRT depletion activates the mTORC2‐driven AKT/β‐catenin signaling axis to enhance clonogenic and invasive phenotypes. Furthermore, lung‐specific Naprt deletion significantly increases tumor burden in
Myung Joon Oh   +11 more
wiley   +1 more source

Growth, yield, and secondary metabolite responses of three shallot cultivars at different watering intervals

open access: yesOpen Agriculture
Indonesia is a significant producer of shallots, and the country frequently cultivates three distinct varieties: Bima, Trisula, and Sumenep. Each cultivar exhibits distinct characteristics, specifically when grown under suboptimal conditions.
Kusumiyati Kusumiyati   +2 more
doaj   +1 more source

Division of Epidemiology and Surveillance Capacity Development 2005 annual report

open access: yes
The Division of Epidemiology and Surveillance Capacity Development (DESCD) 2005 Annual Report is the division\u2019s first annual report, one that reflects the many changes that DESCD and the Centers for Disease Control and Prevention\u2019s (CDC) global

core  

Early Grade Literacy in Latin America and the Caribbean: Jamaica Stakeholder Mapping and Analysis

open access: yes, 2019
The LAC Reads Capacity Program (LRCP) aims to increase the impact, scale, and sustainability of early grade literacy (EGL) activities in priority countries in Latin America and the Caribbean (Jamaica, Haiti, Dominican Republic, Guatemala, Honduras ...
USAID/LAC Reads Capacity Program
core  

Available Water Capacity (AWC), and field capacity and wilting point volumetric percentages for different soil particle-size classes.

open access: yes, 2019
Available Water Capacity (AWC), and field capacity and wilting point volumetric percentages for different soil particle-size classes.
Lisa Nagaoka (7296266)   +2 more
core   +1 more source

Paclitaxel induces NM2‐dependent cellular contraction through GEF‐H1 dissociation from microtubules and RhoA/ROCK activation in cancer cells

open access: yesMolecular Oncology, EarlyView.
Taxanes are widely used chemotherapeutics whose effects on cellular mechanics remain poorly understood. We show that paclitaxel induces rapid cellular contraction by promoting GEF‐H1 dissociation from microtubules and non‐muscle myosin II activation through RhoA/ROCK.
Gloria Asensio‐Juárez   +5 more
wiley   +1 more source

Mutant p53R273H disrupts PDPK1 homodimerization and contributes to PDPK1 activation

open access: yesMolecular Oncology, EarlyView.
How mutant p53R273H drives AKT signaling is unclear. We show that p53R273H, but not wild‐type, directly binds PDPK1 via a mutation‐dependent conformational change. This interaction disrupts inhibitory PDPK1 homodimerization and enhances AKT phosphorylation.
Mei Chee Lim   +11 more
wiley   +1 more source

Division of Epidemiology and Surveillance Capacity Development 2006 annual report

open access: yes
The Division of Global Public Health Capacity Development (DGPHCD) 2007 Annual Report is the third annual report. Since our last report, several organizational changes have occurred resulting in a name change and the addition of a program to our division.

core  

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy